Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Mahmoud Ahmed Gharib"'
Autor:
Marehan Mohammed Elaweel, Walid Mohamed Elnagar, Mohamed El-Bakry Lashin, Mahmoud Ahmed Gharib
Publikováno v:
Zagazig University Medical Journal. 25:481-489
Background: Morbidly adherent placenta (MAP) defines the abnormal adherence of the placenta to the underlying uterine wall. It has a rising incidence world-wide. The risk of placental abnormalities increases in the presence of uterine scars due to ce
Autor:
Amr Aboelfath, Ahmed Abd El Kader, Mahmoud Ahmed Gharib, Abdelaziz I. Amin, Abdel Moneim A. Saleh
Publikováno v:
Zagazig University Medical Journal.
Publikováno v:
Zagazig University Medical Journal.
Publikováno v:
Zagazig University Medical Journal.
Publikováno v:
Zagazig University Medical Journal.
Background: labor induction between 41 and 42 weeks of gestation reduce the adverse perinatal risks. Aim of work: to determine the effect of intravenous dexamethazone administration on preparing the cervix and duration of labor induction in term preg
Publikováno v:
Zagazig University Medical Journal. 22:1-12
Background & objectives: Preeclampsia (PE) is a hypertension disorder of pregnancy that develop in 4-5% . Elevated blood pressure and proteinuria after 20 weeks of conception characterizing the disease. Its complication including a major cause of mor
Autor:
Mahmoud Ahmed Gharib, Yostina Maher Rashid, Mahmoud Hussein El-Shoeiby, Nagy Mohammed Metwally
Publikováno v:
International Journal of Reproduction, Contraception, Obstetrics and Gynecology. 7:4575
Background: The aim of this study is to assess ovarian cancer epidemiology and detect its prognostic factors in Assuit, Egypt.Methods: This retrospective study was performed between January 2010 and December 2015, on all cases attending to Obstetrics
Autor:
Aziz Saleh, Abdel Moneim Abdel1, Gharib, Mahmoud Ahmed1, Amin, Abdelaziz Ibrahim1, El Kader, Ahmed Mohamed Abd1, Aboelfath, Amr Mostafa1 amr_gyn@yahoo.com
Publikováno v:
Zagazig University Medical Journal. Jan2023, Vol. 29 Issue 1, p1-8. 8p.
Autor:
Somia H. Abd-Allah, Sheren M. Shabrawy, Hanan A. Awad, Mona G. Amer, Mahmoud Ahmed Gharib, Amal A. Raslan, Amal S. El-Shal, Heba F. Pasha, Eman A. El Gendy, Nermin Raafat, Sally M. Shalaby, Hassan M. El-Kelawy
Publikováno v:
Cytotherapy. 15(1)
Background No curative treatment is known for primary ovarian failure; however, mesenchymal stem cells (MSCs), through self-renewal and regeneration, push the trial to evaluate their role in the treatment of ovarian failure. The aim of this study was